Reuters Novo Nordisk launches Wegovy pill to US self-pay patients | REUTERS

Danish drugmaker Novo Nordisk is launching its once-daily Wegovy pill in the United States, offering 1.5 milligram (mg) and 4 mg doses at $149 per month for self-paying patients in an intensely competitive weight-loss drug market.

#News #Reuters #Newsfeed #novonordisk #wegovy #wegovyweightloss

Read the story here: https://reut.rs/49D9oU9

👉 Subscribe: http://smarturl.it/reuterssubscribe

Keep up with the latest news from around the world: https://www.reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en

Watch the full video on YouTube